Table 1.
Study Population (n = 9) | |
---|---|
Age (years) | 73.0 (70.0–76.0) |
Gender ratio (M:F) | 5:4 |
Height (cm) | 169.0 (160.5–178.0) |
Bodyweight (kg) | 84.0 (73.5–91.4) |
BMI 1 (kg/m2) | 26.9 (25.0–32.7) |
Smoking; n (%) | 1 (11.1) |
Alcohol; n (%) | 1 (11.1) |
Comorbidity; n (%) | |
Cardiovascular disease | 7 (77.8) |
Pulmonary disease | 5 (55.6) |
History of abdominal surgery | 2 (22.2) |
History of other malignancy | 2 (22.2) |
ASA score 2; n (%) | |
II | 7 (77.8) |
III | 2 (22.2) |
GFI 3; n (%) | |
0 | 1 (11.1) |
I | 2 (22.2) |
II | 1 (11.1) |
III | 1 (11.1) |
IV | 2 (22.2) |
V | 2 (22.2) |
SNAQ 4; n (%) | |
0 | 6 (66.7) |
I | 2 (22.2) |
V | 1 (11.1) |
Diagnosis; n | |
Malignancy | 8 |
Liver metastasis at diagnosis | 1 |
Premalignancy | 1 |
Adjuvant treatment; n | |
Neoadjuvant chemoradiation | 2 |
Adjuvant chemotherapy | 1 |
1 BMI: body mass index; 2 ASA: American Society of Anesthesiologists physical status classification system; 3 GFI: Geriatric Frailty Index, 4 SNAQ: Short Nutritional Assessment Questionnaire.